Licensing Litigation Webinar 
The IPKat
MAY 20, 2024
In this webinar, Sir Robin and Dheemanth will explore the requirement’s origins, how it has been applied by EPO and the English courts in recent years, and what they envisage for the requirement’s future. Webinar - The "Taylor’s Version Strategy" or re-recording music albums: (legally) possible in EU too? (13 To sign up, click here.
SpicyIP
OCTOBER 31, 2023
Image from here Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“ CL ”) for breast cancer medications, Ribociclib and Abemaciclib. It also says that no licenses were given out. – It imposes a burden of 17.7 million disability-adjusted life years (DALYs).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Velocity of Content
MAY 1, 2024
29 town hall, The Heart of the Matter: Copyright, AI Training and LLMs, presented a comprehensive case that AI systems do infringe copyrights and called for a licensing system to compensate content owners. The legal discussion concluded by making the case for the licensing of copyrighted materials for use in LLMs and AI applications.
The IPKat
JANUARY 31, 2024
Two webinars on trade secrets in the EU On February 8, the European Communities Trademark Association (ECTA) and the Bulgarian Patent Office will jointly host a webinar on the EU Trade Secrets Directive. Here’s this week’s selection of opportunities and events for the IPKat community!
Velocity of Content
APRIL 30, 2024
You can read a detailed account of the webinar in the May 2024 issue of Information Today. A few days after the webinar, I met via Zoom with Marmanis and Rowland. We explored the webinar topics in more depth, and the following is our edited and abridged conversation. What role might CCC play in licensing for AI applications?
The IPKat
APRIL 14, 2024
The Licensing Executives Society International (LESI) annual conference will be held from 28 to 30 April 2024 in Madrid, Spain. The program includes life sciences and artificial intelligence, Unified Patent Court (UPC) litigation, EU Data Act requirements, IP management topics across diverse fields and countries, and a gala dinner.
JD Supra Law
DECEMBER 14, 2021
A number of small providers are receiving patent demand letters with a settlement or licensing offer to avoid litigation. Join us to learn about patent infringement claims, NPEs and other entities who send demand letters, the litigation process, and things you should consider when deciding on an. How should you respond?
Expert insights. Personalized for you.
64 
Let's personalize your content